PROCEDURAL ISSUES IN HEALTH TECHNOLOGY ASSESSMENT (HTA) FOR RE-PRICING IN JAPAN

被引：0
|
作者：
Igarashi, A. [1 ]
Aranishi, T. [2 ]
Nakajima, A. [3 ]
Sakai, H. [4 ]
Naoi, I [5 ]
Atsumi, J. [6 ]
Okuyama, K. [7 ]
Azuma, M. K. [4 ]
Machida, M. [8 ]
Yoshida, M. [9 ]
Nojima, T. [10 ]
Kawata, Y. [11 ]
机构：
[1] Yokohama City Univ, Sch Med, Yokohama, Kanagawa, Japan
[2] Eli Lilly Japan KK, Kobe, Hyogo, Japan
[3] Teijin Pharma Ltd, Tokyo, Japan
[4] Eisai & Co Ltd, Tokyo, Japan
[5] Sumitomo Pharma Co Ltd, Chuo Ku, Osaka 13, Japan
[6] Toray Industries Ltd, Tokyo, Japan
[7] MSD KK, Tokyo, Japan
[8] Shionogi & Co Ltd, Osaka, Japan
[9] Pfizer R&D Japan GK, Tokyo, Japan
[10] Kowa Co Ltd, Tokyo, Japan
[11] Chugai Pharmaceut Co Ltd, Tokyo, Japan
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
HTA126
引用
收藏
页码：S320 / S321
页数：2
相关论文
共 50 条
  • [31] Landscape analysis of health technology assessment (HTA): systems and practices in Asia
    Teerawattananon, Yot
    Rattanavipapong, Waranya
    Lin, Lydia Wenxin
    Dabak, Saudamini Vishwanath
    Gibbons, Brent
    Isaranuwatchai, Wanrudee
    Toh, Kai Yee
    Cher, Boon Piang
    Pearce, Fiona
    Bayani, Diana Beatriz S.
    Nakamura, Ryota
    Pwu, Raoh-Fang
    Shafie, Asrul Akmal
    Adhikari, Deepika
    Prinja, Shankar
    Babidge, Wendy
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2019, 35 (06) : 416 - 421
  • [32] Ethical challenges for Health Technology Assessment (HTA) in the evolving evidence landscape
    Refolo, Pietro
    Duthie, Katherine
    Hofmann, Bjorn
    Stanak, Michal
    Bertelsen, Neil
    Bloemen, Bart
    Di Bidino, Rosella
    Oortwijn, Wija
    Raimondi, Costanza
    Sacchini, Dario
    van der Wilt, Gert Jan
    Bond, Kenneth
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2024, 40 (01)
  • [33] Incorporating Patient Preferences for Cancer Treatments into Health Technology Assessment (HTA)
    Oedingen, Carina
    Marshall, Deborah
    MacDonald, Karen
    Stein, Barry
    PATIENT-PATIENT CENTERED OUTCOMES RESEARCH, 2024, 17 (06): : 728 - 728
  • [34] Health Technology Assessment (HTA) in Peru: current situation and future challenges
    Reyes, Nora
    Huaman, Karen
    Neyra-Rivera, Carlos D.
    Acevedo-Flores, Jessica
    Perez-Acuna, Katherine
    Morales-Barrenechea, Javier
    Gutierrez-Aguado, Alfonso
    Gutierrez, Ericson L.
    REVISTA DEL CUERPO MEDICO DEL HOSPITAL NACIONAL ALMANZOR AGUINAGA ASENJO, 2022, 15
  • [35] The concept of health technology assessment -: Views of applicants to funding of HTA projects
    Lange, M
    Jorgensen, T
    Kristensen, FB
    Stilvén, S
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2000, 16 (04) : 1201 - 1209
  • [36] Analysis of Health Technology Assessment (HTA) Procedures and Outcomes for Orphan Drugs
    Warttig, S.
    D'Souza, V
    VALUE IN HEALTH, 2022, 25 (12) : S334 - S335
  • [37] COMPARING THE HTA CORE MODEL WITH A NATIONAL HEALTH TECHNOLOGY ASSESSMENT REPORT
    Pasternack, Iris
    de Groot, Ingrid
    Kleijnen, Sarah
    Polman, Paula
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2014, 30 (05) : 530 - 535
  • [38] Health technology assessment (HTA) organizations: dimensions of the institutional and political framework
    Dutilh Novaes, Hillegonda Maria
    de Soarez, Patricia Coelho
    CADERNOS DE SAUDE PUBLICA, 2016, 32
  • [39] The introduction of Health Technology Assessment (HTA) in Greece and comparison with the European experience
    Mentis, I
    ARCHIVES OF HELLENIC MEDICINE, 2022, 39 (03): : 313 - 321
  • [40] PUBLIC ENGAGMENT MECHANISMS IN HEALTH TECHNOLOGY ASSESSMENT (HTA): AN EARLY ASSESSMENT OF CANADA'S NATIONAL HTA PUBLIC ENGAGEMENT INITIATIVES
    Tran, J. B.
    VALUE IN HEALTH, 2013, 16 (03) : A244 - A244
12345